NCT02283788View on ClinicalTrials.gov

Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Epilepsy
Interventions
DRUG

BIA 2-093

DRUG

Moxifloxacin

DRUG

Placebo

Trial Locations (1)

33025

Comprehensive Phase OneTM, Miramar

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02283788 - Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization | Biotech Hunter | Biotech Hunter